Zymeworks Inc. reported on January 6, 2026, an estimated cash resource of approximately $270.6 million as of December 31, 2025, while announcing key executive appointments and terminations, including the appointment of Brian Cherry as a new director and the termination of CFO Leone Patterson. The company anticipates being funded for operations beyond 2028, contingent on regulatory payments and a share repurchase plan.